BR112022000242A2 - Combinação de ibuprofeno e tramadol para alívio da dor - Google Patents

Combinação de ibuprofeno e tramadol para alívio da dor

Info

Publication number
BR112022000242A2
BR112022000242A2 BR112022000242A BR112022000242A BR112022000242A2 BR 112022000242 A2 BR112022000242 A2 BR 112022000242A2 BR 112022000242 A BR112022000242 A BR 112022000242A BR 112022000242 A BR112022000242 A BR 112022000242A BR 112022000242 A2 BR112022000242 A2 BR 112022000242A2
Authority
BR
Brazil
Prior art keywords
ibuprofen
tramadol
combination
pain
pain relief
Prior art date
Application number
BR112022000242A
Other languages
English (en)
Portuguese (pt)
Inventor
Gómez Calvo Antonia
Portolés Pérez Antonio
Calandria Pérez Carlos
Vargas Castrillón Emilio
Duart Gonzalez Ester
García Alonso Fernando
Angel Sánchez García Jose
Narciso Santé Serna Luis
Vicario de la Torre Marta
Del Rosario Salas Butrón María
Sanz Menéndez Nuria
Horcajada Córdoba Raquel
José Muñoz Ruiz Ángel
Original Assignee
Farmalider Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider Sa filed Critical Farmalider Sa
Publication of BR112022000242A2 publication Critical patent/BR112022000242A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
BR112022000242A 2019-07-09 2020-07-08 Combinação de ibuprofeno e tramadol para alívio da dor BR112022000242A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19382583 2019-07-09
PCT/EP2020/069306 WO2021005129A1 (en) 2019-07-09 2020-07-08 Combination of ibuprofen and tramadol for relieving pain

Publications (1)

Publication Number Publication Date
BR112022000242A2 true BR112022000242A2 (pt) 2022-05-31

Family

ID=67480112

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022000242A BR112022000242A2 (pt) 2019-07-09 2020-07-08 Combinação de ibuprofeno e tramadol para alívio da dor

Country Status (21)

Country Link
US (1) US12514833B2 (https=)
EP (1) EP3996699B1 (https=)
JP (1) JP7656339B2 (https=)
CN (1) CN114080221B (https=)
AU (1) AU2020309160B2 (https=)
BR (1) BR112022000242A2 (https=)
CA (1) CA3145632C (https=)
DK (1) DK3996699T3 (https=)
ES (1) ES2952013T3 (https=)
FI (1) FI3996699T3 (https=)
HR (1) HRP20230677T1 (https=)
HU (1) HUE062529T2 (https=)
MA (1) MA56341B1 (https=)
MD (1) MD3996699T2 (https=)
MX (1) MX2022000373A (https=)
MY (1) MY207573A (https=)
PL (1) PL3996699T3 (https=)
PT (1) PT3996699T (https=)
RS (1) RS64500B1 (https=)
SI (1) SI3996699T1 (https=)
WO (1) WO2021005129A1 (https=)

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US5516803A (en) * 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
IT1264857B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
IT1264855B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
US6348216B1 (en) 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
PL348808A1 (en) 1998-11-02 2002-06-17 Ortho Mcneil Pharm Inc Analgesic regimen
US6251945B1 (en) 1999-01-14 2001-06-26 Knoll Aktiengesellschaft Pharmaceutical mixture comprising a combination of a profen and other active compounds
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US6342530B1 (en) 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
DE60114249T2 (de) 2001-11-02 2006-05-18 Cumberland Pharmaceuticals Inc., Nashville Pharmazeutische zusammensetzung mit 2-(4-isobutylphenyl) propionsäure
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
EP1558234B1 (en) 2002-10-25 2007-05-23 Dompé S.P.A. Painless injectable compositions containing salt of 2-arylpropionic acids
US20070117826A1 (en) * 2005-11-23 2007-05-24 Forest Laboratories, Inc. Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone
EP2149546A1 (en) * 2008-07-31 2010-02-03 Laboratorios Del. Dr. Esteve, S.A. Salts of tramadol and ibuprofen and their crystal form in the treatment of pain
EP2381937A2 (en) 2008-12-31 2011-11-02 Upsher-Smith Laboratories, Inc. Opioid-containing oral pharmaceutical compositions and methods
KR20140014350A (ko) 2009-03-12 2014-02-06 큠버랜드 파마슈티컬즈 인코포레이티드 정맥 내 투여용 이부프로펜의 투여
US8871810B2 (en) 2009-07-15 2014-10-28 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
US8735452B2 (en) 2009-07-15 2014-05-27 Cumberland Pharmaceuticals Inc. Treating patients with intravenous ibuprofen
ES2356762B1 (es) * 2009-09-04 2011-11-24 Farmalider S.A. Composicion farmaceutica de ibuprofeno, tramadol y un aminoacido basico, procedimiento para su preparacion y utilizacion de la misma.
MX2010004974A (es) 2010-05-04 2011-11-23 Senosiain S A De C V Lab Combinacion de un aine y un aminoacido.
CA2833307C (en) 2011-04-12 2018-01-23 Revogenex Inc. Intravenous administration of tramadol
US9351926B2 (en) 2012-02-20 2016-05-31 Pharmaceutical Solutions Industry Ltd. Ibuprofen intravenous infusion
ES2423866B1 (es) 2012-02-22 2014-06-10 Farmalider, S.A. Composición farmaceútica de ibuprofeno y tramadol para inyección
ES2540151B1 (es) * 2013-10-11 2016-02-29 Farmalider S.A. Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico
BR112016023628A2 (pt) * 2014-04-10 2018-05-15 Charleston Laboratories Inc composições farmacêuticas.

Also Published As

Publication number Publication date
CA3145632A1 (en) 2021-01-14
CA3145632C (en) 2024-03-12
WO2021005129A1 (en) 2021-01-14
JP7656339B2 (ja) 2025-04-03
MD3996699T2 (ro) 2023-11-30
US20220249414A1 (en) 2022-08-11
US12514833B2 (en) 2026-01-06
ES2952013T3 (es) 2023-10-26
HUE062529T2 (hu) 2023-11-28
JP2022540854A (ja) 2022-09-20
RS64500B1 (sr) 2023-09-29
EP3996699B1 (en) 2023-06-28
PT3996699T (pt) 2023-07-27
AU2020309160B2 (en) 2025-06-26
DK3996699T3 (da) 2023-07-24
FI3996699T3 (fi) 2023-08-01
CN114080221A (zh) 2022-02-22
SI3996699T1 (sl) 2023-10-30
MX2022000373A (es) 2022-02-10
MA56341B1 (fr) 2023-07-31
EP3996699A1 (en) 2022-05-18
CN114080221B (zh) 2023-12-05
AU2020309160A1 (en) 2022-02-17
PL3996699T3 (pl) 2023-10-30
HRP20230677T1 (hr) 2023-10-13
MY207573A (en) 2025-03-05

Similar Documents

Publication Publication Date Title
BR112014004845A2 (pt) pelo menos uma entidade química; pelo menos um composto; composição farmacêutica; uso de uma quantidade terapeuticamente eficaz de pelo menos uma entidade química; composição farmacêutica embalada
BR112015029918A2 (pt) uso de alta dose de pridopidina para tratar a doença de huntington
BR112014004741A2 (pt) pelo menos uma entidade química; composição farmacêutica; uso de uma quantidade terapeuticamente eficaz de pelo menos uma entidade química; composição farmacêutica embalada
BR112015029491A2 (pt) derivados de imidazopirrolidinona e seu uso no tratamento de doença
BR112015029512A8 (pt) derivados de pirazolopirrolidina, seus usos, e composição e combinação farmacêuticas
BRPI0507966A (pt) uso de meloxicam para o tratamento de doenças respiratórias em porcos
PH12012501480A1 (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
PE20142319A1 (es) Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero
BR112015029401A2 (pt) derivados pirazolo-pirrolidin-4-ona e seu uso no tratamento de doenças
AR085662A1 (es) Metodos y composiciones para tratar la hiperuricemia y trastornos metabolicos asociados con la hiperuricemia
MX2014001088A (es) Ciertos inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas, y metodos de uso de las mismas.
BR112020019875A8 (pt) composições tópicas para alívio da dor
AR089862A1 (es) USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA
BR112017016087A2 (pt) formulações para coxim articular adiposo e métodos de uso das mesmas
JP2016510343A5 (https=)
BR112019002513A2 (pt) uso e dosagem de agentes terapêuticos para endometriose
BRPI0514043A (pt) medicamentos para tratar doença respiratória crÈnica
BR112023025552A2 (pt) Composições estabilizadas de apilimod e usos das mesmas
BR112015012497A8 (pt) combinações e composições farmacêuticas, seus usos, preparação combinada, e embalagem comercial
BR112012020377A2 (pt) utilização de um ou mais selecionado do grupo constituído por um composto da fórmula (i), uma mistura racêmica-diastereomérica e um isômero óptico do referido composto, e um sal farmaceuticamente aceitável e uma pródroga do mesmo, método, composição farmacêutica e kit para tratamento de caquexia e embalagem comercial
BR112019005214A2 (pt) composição farmacêutica compreendendo antagonista do receptor de mineralocorticoide e uso da mesma
AR099299A1 (es) Inhibidor de la proteína de transferencia de éster de colesterilo (cetp) y composiciones farmacéuticas que comprenden dicho inhibidor para uso en el tratamiento o prevención de enfermedades cardiovasculares
BR112018072177A2 (pt) composição farmacêutica, recipiente, e, métodos para tratar e prevenir congestão nasal, infecções virais do trato respiratório e/ou inflamação da garganta
CO2018009543A2 (es) Composición farmacéutica de liberación prolongada que comprende cisteamina o sal de la misma
BR112022000242A2 (pt) Combinação de ibuprofeno e tramadol para alívio da dor

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]